Natamycin

Natamycin (also known as pimaricin) is a polyene macrolide antibiotic with the CAS number 7681-93-8. It is produced through fermentation by the bacterium Streptomyces natalensis. Natamycin functions as an antifungal agent by disrupting fungal cell membranes, making it effective at preventing mold and yeast growth in food products. The compound is a naturally derived additive rather than a synthetic chemical.

Natamycin is primarily used as a food preservative in dairy products, particularly in cheese production where it prevents surface mold growth. It is also employed in other foods including yogurt, sour cream, and certain processed meat products. The additive is typically applied as a surface treatment or incorporated into food formulations at very low concentrations, generally ranging from 10-400 ppm depending on the food category and regional regulations. Its antifungal properties make it particularly valuable for products that are prone to mold contamination during storage and distribution.

Natamycin has not been granted GRAS (Generally Recognized as Safe) status by the FDA, though it remains approved for specific food applications. The FDA has recorded zero adverse events associated with natamycin consumption, and there have been no recalls related to this additive. The compound's safety profile is supported by its rapid degradation in the gastrointestinal tract and minimal systemic absorption when ingested orally at typical food use levels.

The European Food Safety Authority (EFSA) has evaluated natamycin and established acceptable daily intake levels. Toxicological studies in animal models have demonstrated low acute toxicity, and chronic exposure studies have not revealed significant health concerns at approved use levels. The additive is not genotoxic or mutagenic based on available scientific literature.

Because natamycin is an antibiotic, there has been theoretical concern regarding potential impacts on human microbiota. However, the quantities used in food are extremely small, and the antimicrobial spectrum is limited primarily to fungi rather than bacteria, reducing concerns about selective pressure on bacterial populations.

Natamycin's regulatory status varies internationally. In the United States, while not GRAS-listed, natamycin is approved by the FDA as a food additive for specific uses in cheese (21 CFR 172.131). The European Union permits natamycin (E235) as a food additive with established maximum residue levels. It is also approved in Canada, Australia, and many other countries for use in cheese and select dairy products.

The additive must meet specific purity standards and identity requirements established by food regulatory agencies. Approved use levels are significantly lower than those shown to produce effects in safety studies, providing a substantial safety margin.

Multiple safety evaluations have been conducted on natamycin, including comprehensive reviews by the Joint FAO/WHO Expert Committee on Food Additives (JECFA). These evaluations concluded that natamycin is safe for use in food at approved levels. Pharmacokinetic studies demonstrate that oral natamycin is poorly absorbed in the human gastrointestinal tract, with most of the compound being excreted unchanged in feces, limiting systemic exposure. In vitro and animal studies confirm that natamycin's antimicrobial activity is predominantly antifungal, with minimal effects on common bacterial species at food-relevant concentrations.